SCHEMBL4179640

SCHEMBL4179640

O=C(O)c1ccc(-c2ncc(Cl)cc2Cl)c(Cl)c1

nearest known ligand 0.49

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TSHR P16473 2/20 0.49
SRD5A2 P31213 3/20 0.48
MAPT P10636 1/20 0.47
KDM4C Q9H3R0 1/20 0.43
SRD5A1 P18405 1/20 0.43
HCAR2 Q8TDS4 1/20 0.42
NAPRT Q6XQN6 1/20 0.42
ADH5 P11766 2/20 0.42
KDM4E B2RXH2 1/20 0.42
NPC1 O15118 1/20 0.42
CRHBP P24387 1/20 0.42
RAB9A P51151 1/20 0.42
CRHR2 Q13324 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
TNKS2 Q9H2K2 1/20 0.41
CNR1 P21554 2/20 0.41
ALOX15 P16050 1/20 0.40
TRPM8 Q7Z2W7 1/20 0.40
CHEK2 O96017 1/20 0.40
CDH1 P12830 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3340692 0.88 TSHR (0.49) TSHRSRD5A2MAPTSRD5A1HCAR2
SCHEMBL4183721 0.81 GLA (0.51) MAPTKDM4ENPC1RAB9ASMN1; SMN2
SCHEMBL4186527 0.81 ADH5 (0.58) TSHRSRD5A2HCAR2NAPRTADH5
SCHEMBL16502673 0.79 IP6K1 (0.42) TSHRMAPTNAPRTRAB9ATRPM8
SCHEMBL9907732 0.79 SRD5A2 (0.49) SRD5A2MAPTKDM4CSRD5A1KDM4E
SCHEMBL4186704 0.78 TSHR (0.49) TSHRADH5KDM4ESMN1; SMN2
SCHEMBL2769863 0.77 TSHR (0.71) TSHRSRD5A2MAPTSRD5A1ADH5
SCHEMBL6250304 0.76 MAP4K4 (0.50) TSHRKDM4CNAPRTKDM4ENPC1
SCHEMBL9907696 0.76 HTR5A (0.59) SRD5A2MAPTKDM4CSRD5A1KDM4E
Hydrochloric Acid SCHEMBL9812972 0.75 TSHR (0.68) TSHRSRD5A2MAPTSRD5A1ADH5

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9199965-B2 Benzoimidazole derivatives and pharmaceutical composition comprising the same DAEWOONG CO., LTD. (KR) 2015-12-01 US disclosed
EP-1861387-B1 BENZIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITIONS THEREOF DAE WOONG PHARMA (KR) 2014-04-16 EP disclosed
CN-101128452-B Novel benzimidazole derivatives and pharmaceutical compositions containing the same DAE WOONG PHARMA 2012-11-21 CN disclosed
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2009-01-15 US disclosed
CN-101128452-A Novel benzimidazole derivatives and pharmaceutical compositions containing the same DAE WOONG PHARMA (KR) 2008-02-20 CN disclosed
EP-1861387-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2007-12-05 EP disclosed
WO-2006080821-A1 NOVEL BENZOIMIDAZOLE DERIVATIVES AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME DAEWOONG PHARMACEUTICAL CO., LTD. (KR) 2006-08-03 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090018124-A1 Novel Benzoimidazole Derivatives and Pharmaceutical Composition Comprising the Same TRPV1, TRPA1, BDKRB2 TSHR 2576/4885SRD5A2 3762/4885MAPT 2014/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.